NCT06110923View on ClinicalTrials.gov

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Benign Prostate Hypertrophy(BPH)
Interventions
DRUG

CKD-846

once administration of Investigational Product

DRUG

D091

once administration of Investigational Product per day

Trial Locations (1)

Unknown

RECRUITING

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY